CIK 0001401914
- Non-accelerated filer
- Smaller reporting company
Dare Bioscience, Inc.
Sign in to watch- Ticker
- DARE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 204139823
- Phone
- +1 858-926-7655
- Business address
- 3655 NOBEL DRIVE, SUITE 260, SAN DIEGO, CA, 92122
- Former names
- Cerulean Pharma Inc., Tempo Pharmaceuticals Inc
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Principal Accounting Officer acquired 1,098 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 2,291 shares at an average $2.08 ($4,763)
- 4 Open-market buy Director bought 8,960 shares at an average $2.10 ($18,842)
- 4 Open-market buy Director bought 8,811 shares at an average $2.00 ($17,645)
- 4 Open-market buy Director bought 8,850 shares at an average $2.05 ($18,172)
- 4 Open-market buy Director bought 9,000 shares at an average $2.15 ($19,318)
- 4 Open-market buy Director bought 8,563 shares at an average $2.30 ($19,706)
- 4 Open-market buy Director bought 8,413 shares at an average $2.32 ($19,540)
- 4 Open-market buy Director bought 5,700 shares at an average $2.38 ($13,550)
- 4 Open-market buy Director bought 9,000 shares at an average $2.46 ($22,132)
- 4 Open-market buy Director bought 8,800 shares at an average $2.39 ($21,075)
- 4 Open-market buy Director bought 9,000 shares at an average $2.28 ($20,523)
- 4 Open-market buy Director bought 8,900 shares at an average $2.43 ($21,660)
- 4 Open-market buy Director bought 8,572 shares at an average $2.53 ($21,711)
- 4 Open-market buy Director bought 8,684 shares at an average $2.79 ($24,209)
- 4 Open-market buy Director bought 8,855 shares at an average $2.87 ($25,408)
Page 8 of 12 · 240 filings